New catheter aims to treat dangerous blood clots in the lungs without ICU stay
Disease control
Recruiting now
This trial tests a special catheter that delivers clot-dissolving medication directly into the lung arteries of people with intermediate-risk pulmonary embolism. The goal is to see if this targeted approach can safely treat the clot without needing intensive care or a continuous …
Phase: NA • Sponsor: Thrombolex, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC